VcMMAE-Deruxtecan is a targeted drug-linker conjugate designed for antibody-drug conjugate (ADC) applications. This compound combines a cytotoxic microtubule inhibitor, MMAE, with Exatecan, a DNA topoisomerase I inhibitor, facilitating precise targeting of cancer cells. VcMMAE-Deruxtecan is primarily utilized in the synthesis of ADCs, contributing to advancements in cancer therapeutics.
VcMMAE-Deruxtecan is a targeted drug-linker conjugate designed for antibody-drug conjugate (ADC) applications. This compound combines a cytotoxic microtubule inhibitor, MMAE, with Exatecan, a DNA topoisomerase I inhibitor, facilitating precise targeting of cancer cells. VcMMAE-Deruxtecan is primarily utilized in the synthesis of ADCs, contributing to advancements in cancer therapeutics.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: